Speaker

Jennifer Petter, Arrakis Therapeutics, USA
bio-petter

Dr. the Founder and Chief Scientific Officer of Arrakis Therapeutics.  Previously she was Vice President of Chemistry at Celgene, Vice President of Drug Discovery at Avila Therapeutics, Vice President of Research at Mersana Therapeutics, Director of Small Molecule Drug Discovery at Biogen, Section Head in Oncology Chemistry at Sandoz/Novartis, and Assistant Professor of Chemistry at the University of Pittsburgh.  Dr. Petter graduated from Dartmouth College with an AB in chemistry, earned her PhD in organic chemistry at Duke University with Ned Porter, and was a post-doctoral fellow in Ron Breslow’s group at Columbia University.  She has ushered a dozen compounds into the clinic for the treatment of cancer, cardiovascular disease, autoimmune disorders, and sepsis.

« Go Back

Register Now Submit Abstract